Here are five things to know:
1. Mr. Lucier purchased 34,000 shares.
2. The shares were purchased at $49.25 on average.
3. The total transaction value was $1.6 million.
4. There are 1.54 percent of the shares held by the company insiders and 99 percent are held by institutions.
5. NuVasive’s market cap is $2.3 billion.
Mr. Lucier assumed the company’s top position after the former CEO stepped down due to compliance issues.
More articles on orthopedic devices:
LESS Institute gets $30M senior credit facility—5 key notes
8 key trends in the global 3D printing medical applications market
Medtronic sets its sights on China—5 things to know
